Trending...
- Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago - 117
- Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations - 108
- $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
Media Contact: LARA Communications 517-335-LARA (5272)
Email: mediainfo@michigan.gov
January 13, 2020 – The Marijuana Regulatory Agency (MRA) issued a health and safety advisory bulletin on Friday, January 10, 2020 due to the recall of medical marijuana product which failed safety compliance testing.
All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for the production batch number associated with the product name or the individual package number which can be found under the name of the provisioning center at which the product was sold.
More on Michimich.com
This recall affects the following products sold at three provisioning centers in the state of Michigan between 10/14/2019 and 1/6/2020:
Production batch: 1A4050100002330000000009
Product name: Orange Burst – Buds
Failed testing: Chemical Residue (Paclobutrazol)
Pharmaco, Inc. (License # PC-000249)
3650 Patterson RD
Bay City MI 48706
Individual Package # 1A4050100002330000000415
Pharmaco, Inc. (License # PC-000261)
3557 Wilder RD
Bay City MI 48706
Individual Package # 1A4050100002330000000416
Pharmaco, Inc. (License # PC-000205)
20561 Dwyer ST
Detroit MI 48234
Individual Package # 1A405010000233000000041
Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased for proper disposal. Provisioning centers who carried the products must notify patients or caregivers who purchased these medical marijuana products of the recall.
Email: mediainfo@michigan.gov
January 13, 2020 – The Marijuana Regulatory Agency (MRA) issued a health and safety advisory bulletin on Friday, January 10, 2020 due to the recall of medical marijuana product which failed safety compliance testing.
All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for the production batch number associated with the product name or the individual package number which can be found under the name of the provisioning center at which the product was sold.
More on Michimich.com
- Image Printing Company, Inc. Awarded GSA Multiple Award Schedule Contract, Expanding Federal Printing Capabilities
- Logicalis US Named to CRN's Tech Elite 250 for 2026
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
This recall affects the following products sold at three provisioning centers in the state of Michigan between 10/14/2019 and 1/6/2020:
Production batch: 1A4050100002330000000009
Product name: Orange Burst – Buds
Failed testing: Chemical Residue (Paclobutrazol)
Pharmaco, Inc. (License # PC-000249)
3650 Patterson RD
Bay City MI 48706
Individual Package # 1A4050100002330000000415
Pharmaco, Inc. (License # PC-000261)
3557 Wilder RD
Bay City MI 48706
Individual Package # 1A4050100002330000000416
Pharmaco, Inc. (License # PC-000205)
20561 Dwyer ST
Detroit MI 48234
Individual Package # 1A405010000233000000041
Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased for proper disposal. Provisioning centers who carried the products must notify patients or caregivers who purchased these medical marijuana products of the recall.
0 Comments
Latest on Michimich.com
- Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers
- Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
- Michigan Faces Challenges From Climate Change: Flooding, Foundation Leaks, And Aging Sewers
- The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
- The State of Law Firm Marketing: Top Companies, Awards, and Resources
- Michigan SEO Group Announces New Internet Marketing Specialist
- USA Best Book Awards Finalist What Love Leaves Behind Releases March 24
- Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
- ENTOUCH Named Finalist for 2026 North American Inspiring Workplaces Awards
- Wilderness Construction Helps Ann Arbor Homeowners Navigate the Paint vs. Replace Cabinet Decision
- Cleveland County Goat Farm NC Kikos Featured in "Feature Farmer Friday" Documentary
- Tony Grundler Introduces Artificial Intelligence V.S. Avatar-Ian's
- Sterling Heights City Council Opposes HB 5529-5532; Supports Locally Driven Housing Solutions
- Sterling Heights: Soak Up Spring this April with #MYSHPR
- Sterling Heights: Library Launches New Authors and Artists Sale Series at Dodge Park Thursdays
- Hollywood's Elite Gather at the Annual WOW Creations Oscars Gifting Suite at the Universal Hilton
- Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
- Calmly Rooted Announces Strategic Evolution of "The Calm Collective" Wellness Hub
- JGCMGS Details Architecture to Safeguard Assets From Unauthorized Phishing Scams
- 21 Days: The Malta Deadline That Could Redraw the Finnish Online Casino Map